HemaSphere (Jun 2022)

P1337: SURVIVAL EFFICACY OF MDS/AML PATIENTS WITH TP53 GENE ALTERATION RECEIVED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

D. Feng,
E. Jiang

Affiliations

D. Feng: 1 Hematological Hospital, Chinese Academy of Medical Sciences, Hematological Hospital, Chinese Academy of Medical Sciences, Tianjin, China
E. Jiang: 1 Hematological Hospital, Chinese Academy of Medical Sciences, Hematological Hospital, Chinese Academy of Medical Sciences, Tianjin, China

DOI: https://doi.org/10.1097/01.HS9.0000848212.69553.69
Journal volume & issue: Vol. 6
pp. 1222 – 1223

Abstract

No abstracts available.

Published in HemaSphere

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.hemaspherejournal.com

About the journal